Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986–2015

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 4, 2017, Pages 614-623

  O’Shaughnessy, Michelle M ^a,b   Hogan, Susan L ^a   Poulton, Caroline J ^a   Falk, Ronald J ^a   Singh, Harsharan K ^a   Nickeleit, Volker ^a   Jennette, J Charles ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult; African Americans; Aged; Antibodies; Antineutrophil Cytoplasmic; Biopsy; Clinical epidemiology; Cross Sectional Studies; Demography; Diabetic Nephropathies; Environmental Exposure; European Continental Ancestry Group; Glomerular disease; Glomerulonephritis; Hispanic Americans; Histopathology; Humans; Kidney Glomerulus; Lipoid; Lupus nephritis; Male; MeSH Browser: Southeastern United States Southeastern United States; Middle Aged; Nephrosis; Renal biopsy

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; ETHNICITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; INFANT; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE NONDENSE DEPOSIT DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; MONOCLONAL IMMUNE DEPOSITION DISEASE; RACE; SEROLOGY; SEX DIFFERENCE; UNITED STATES; YOUNG ADULT; AGED; GLOMERULONEPHRITIS; GLOMERULUS; INCIDENCE; LIPOID NEPHROSIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; TIME FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INCIDENCE; INFANT; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; SOUTHEASTERN UNITED STATES; TIME FACTORS; YOUNG ADULT;

EID: 85021690207     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10871016     Document Type: Article

References (29)

1. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypa-nolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841–845, 2010
2. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP: Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43: 321–327, 2011
3. Hurtado A, Johnson RJ: Hygiene hypothesis and prevalence of glomerulonephritis. Kidney Int Suppl 68: S62–S67, 2005
4. McQuarrie EP, Mackinnon B, McNeice V, Fox JG, Geddes CC: The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation. Kidney Int 85: 198– 203, 2014
5. Braden GL, Mulhern JG, O’Shea MH, Nash SV, Ucci AA Jr., Germain MJ: Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35: 878–883, 2000
6. Dragovic D, Rosenstock JL, Wahl SJ, Panagopoulos G, DeVita MV, Michelis MF: Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin Nephrol 63: 1–7, 2005
7. Haas M, Meehan SM, Karrison TG, Spargo BH: Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30: 621–631, 1997
8. Korbet SM, Genchi RM, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27: 647–651, 1996
9. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol 1: 483–487, 2006
10. Kraus MA, Punj S, Cimbaluk D, Hart PD: Resurgence of membranous nephropathy in African Americans in inner city Chicago. Clin Kidney J 6: 373–378, 2013
11. Pontier PJ, Patel TG: Racial differences in the prevalence and presentation of glomerular disease in adults. Clin Nephrol 42: 79–84, 1994
12. Murugapandian S, Mansour I, Hudeeb M, Hamed K, Hammode E, Bijin B, Daheshpour S, Thajudeen B, Kadambi P: Epidemiology of glomerular disease in southern arizona: Review of 10-year renal biopsy data. Medicine (Baltimore) 95: e3633, 2016
13. D’Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368–382, 2004
14. Ehrenreich TC, Churg J: Pathology of membranous nephropathy. Pathol Annu 3: 145–186, 1968
15. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521–530, 2004
16. Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F: Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44: 193–199, 2007
17. Jennette J, Falk R: Glomerular clinicopathologic syndromes. In: National Kidney Foundation’s Primer on Kidney Disease, edited by Gilbert S, Weiner D, St. Louis, MO, Elsevier, 2013, pp 152–163
18. US Census Bureau: Census Interactive Population Search, 2010. Available at: http://www.census.gov/2010census/popmap/ipmtext. php?fl=37. Accessed January 10, 2017
19. US Census Bureau: Population Change and Distribution, 1990– 2000. Available at: http://www.census.gov/prod/2001pubs/c2kbr01-2.pdf. Accessed January 10, 2017
20. US Census Bureau: Population Distribution and Change, 2000– 2010. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-01.pdf. Accessed January 10, 2017
21. Centers for Disease Control and Prevention (CDC): Increasing prevalence of diagnosed diabetes–United States and Puerto Rico, 1995-2010. MMWR Morb Mortal Wkly Rep 61: 918–921, 2012
22. Sim JJ, Batech M, Hever A, Harrison TN, Avelar T, Kanter MH, Jacobsen SJ: Distribution of biopsy-proven presumed primary glomerulonephropathies in 2000-2011 among a racially and ethnically diverse US population. Am J Kidney Dis 68: 533–544, 2016
23. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 69: 1455–1458, 2006
24. Menke A, Casagrande S, Geiss L, Cowie CC: Prevalence of and trends in diabetes among adults in the united states, 1988-2012. JAMA 314: 1021–1029, 2015
25. Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA: Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 27: 322–328, 2007
26. Yaqub S, Kashif W, Hussain SA: Non-diabetic renal disease in patients with type-2 diabetes mellitus. Saudi J Kidney Dis Transpl 23: 1000–1007, 2012
27. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, Winkelmayer WC, Costenbader KH: Epidemiology and so-ciodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum 65: 753–763, 2013
28. Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M: Excess mortality among persons with type 2 diabetes. N Engl J Med 373: 1720–1732, 2015
29. Slabaugh SL, Curtis BH, Clore G, Fu H, Schuster DP: Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US. J Med Econ 18: 106–112, 2015